A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

NCT07592689 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

165

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

OTHER: Placebo
DRUG: DT120

Sponsor

Definium Therapeutics US, Inc.